How a Liberal Foundation Funded Abortion Pills in the Name of Population Control

(Free Washington Beacon) About a decade before his death in 1996, tech titan David Packard issued a controversial directive to his children. Skyrocketing birth rate, Hewlett-Packard co-founder wrote, could one day cause “total chaos for mankind”. As a result, Packard argued, his multibillion-dollar foundation must have one priority above all others: population control.

Packard – a Republican who served as assistant secretary of defense under President Richard Nixon – disagreed politically with his three daughters, one of whom succeeded him as president of his foundation after his death. His liberal offspring took the billionaire’s desire to curb population growth as a starting point. While the foundation is not legally bound to honor Packard’s political wishes, they have found a way to embrace his views and pursue their own liberal activism – through expanded access to abortion, a mission to which they have spent nearly $350 million in the last five years alone, according to a review of the foundation financial disclosures.

[Click here to subscribe to Pregnancy Help News!]

These expenditures enabled Packard’s successors to win important victories in the pursuit of the late billionaire’s anti-natalist agenda. Take, for example, the Food and Drug Administration December Decision to facilitate the process of obtaining a chemical abortion pill. The Packard Foundation has played a pivotal role in the fight against deregulation, funneling millions to liberal advocacy groups that have spearheaded the legal and policy push to remove FDA barriers to abortion pills. The foundation has meanwhile invested millions of dollars in GenBioPro, the only company that manufactures a generic form of the abortifacient drug.

Tweet this: The Packard Foundation played a central role in the fight to have the FDA facilitate the process of obtaining a chemical abortion pill.

In 2017, the Packard Foundation given $1,000,000 to the Reproductive Freedom Project, a division of the American Civil Liberties Union that works to “ensure that all members of our society have access” to abortion. That year, lawyers for the Reproductive Freedom Project for follow-up the FDA to challenge its restrictions on abortion pills, which required patients to receive abortion pills in person at specialized clinics.

A few months later, in 2018, the foundation invested $500,000 in GenBioPro. The Nevada-based private company manufactures the generic form of mifepristone, an oral medication used to induce abortion. This invested Another $1.5 million in GenBioPro in 2019, the same year the company’s generic abortion pill received FDA approval and hit the market.

At the same time, the foundation has spent millions of dollars on political campaigns promoting increased access to abortion pills. From 2017 to 2021, he reward liberal black money network New Venture Fund over $3.7 million in “reproductive health” grants. The Packard Foundation specifically earmarked $1 million of the contribution to All Above All, a new venture capital fund project that has recommended deregulation of the abortion pill. Also new venture capital fund manages Abortion on Our Own Terms, another spin-off group dedicated to expanding access to abortion pills and envisions a future where abortion pills are available nationwide without a prescription.

Tweet this: The Packard Foundation has dedicated nearly $350 million to expanding access to abortion in the past five years alone.

The Packard Foundation’s extensive abortion pill advocacy network has begun to pay off more recently, thanks in part to the coronavirus pandemic and the election of President Joe Biden.

After receiving a additional $700,000 of the foundation, the ACLU in May 2020 again for follow-up the FDA about the agency’s restrictions on abortion pills. Unlike its 2017 lawsuit — which permanently challenged the regulations — the ACLU’s 2020 legal challenge sought to allow patients to receive abortion pills by mail in an emergency during the pandemic.

The New Venture Fund apparently bolstered this effort by launching a congressional lobbying campaign on “maternal health,” which ran from January at June of 2021. In February, 11 House Democrats sent a letter asking the FDA to lift its “medically unnecessary requirement for in-person delivery of mifepristone” due to the pandemic. After the agency’s April engagement, more than 70 House Democrats followed up with a August Resolution demanding that the FDA allow abortion by mail on a permanent basis. In December, these lawmakers got their wish: the FDA announcement it would permanently lift its restrictions on abortion pills, allowing them to be prescribed virtually and delivered by mail.

GenBioPro, which did not return a request for comment about its relationship with the Packard Foundation, will no doubt benefit from the ruling. In the FDA online explainer of its new abortion pill regulations, the agency noted that GenBioPro’s generic pill “can be safely replaced” with the brand name version of the drug, Mifeprex. The Packard Foundation also helped bring Mifeprex to market, offering its manufacturer, Danco Laboratories, a $14 million loan in 1996.

Tweet this: The Packard Foundation has invested $2 million in GenBioPro, the company that makes the generic form of mifepristone, an abortion pill.

Asked about its investment in GenBioPro and its potential for profitability if the company increases in value, the Packard Foundation pointed to the Free Washington Beacon has a online declaration detailing its investment program. This statement recognizes the foundation “taking[s] risks in pursuit of impact while seeking overall return to principal” so that it “can recycle capital to maximize long-term impacts”.

The foundation declined to comment specifically on its GenBioPro investment. Neither New Venture Fund nor the ACLU returned requests for comment.

Packard Foundation grantees celebrated the FDA’s decision to deregulate the abortion pill. ACLU Senior Legislative Counsel Georgeanne Usova called this decision “is a major step forward that will allow many more patients to obtain this safe and urgently needed medicine when they are ready”. But proponents of the abortion pill were quick to point out that their fight is far from over.

“While today’s action goes a long way for people seeking care, other barriers remain and must be lifted once and for all,” said All Above All Co-Chair Destiny Lopez. noted in a report. “The FDA must permanently lift all restrictions on medical abortion, and states that ban medical abortion for political reasons, especially via telehealth, must reverse those policies so people can get care in a way that makes sense to them.”

Editor’s note: This article was published by the Washington Free Beacon and is reprinted with permission. international heartbeat manages the Abortion Pill Rescue® Network and Pregnancy Help News.

Back To Top